Knockdown of TSP50 inhibits cell proliferation and induces apoptosis in P19 cells

IUBMB Life

Volumn 62, Issue 11, 2010, Pages 825-832

  Liang Zhou, ^a   Bao, Yong Li ^a   Zhang, Yu ^a   Wu, Yin ^a   Yu, Chun Lei ^a   Huang, Yan Xin ^a   Sun, Ying ^a   Zheng, Li Hua ^a   Li, Yu Xin ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

apoptosis; P19; p53; RNAi; TSP50; tumorigenesis

Indexed keywords

PROTEIN P53; PROTEINASE; TESTES SPECIFIC PROTEASE 50; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; DOWN REGULATION; EMBRYONAL CARCINOMA STEM CELL; GENETIC TRANSFECTION; PHENOTYPE; PROTEIN EXPRESSION; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; DOXORUBICIN; GENE KNOCKDOWN TECHNIQUES; MICE; RNA INTERFERENCE; SERINE ENDOPEPTIDASES; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE;

EID: 79952022730     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.390     Document Type: Article

References (48)

1. Yuan, L., Shan, J., De Risi, D., Broome, J., Lovecchio, J., Gal, D., Vinciguerra, V., and, Xu, H. P., (1999) Isolation of a novel gene, TSP50, by a hypomethylated DNA fragment in human breast cancer. Cancer Res. 59, 3215-3221. (Pubitemid 29316025)
2. Xu, H., Shan, J., Jurukovski, V., Yuan, L., Li, J., and, Tian, K., (2007) TSP50 encodes a testis-specific protease and is negatively regulated by p53. Cancer Res. 67, 1239-1245.
3. Shan, J., Yuan, L., Xiao, Q., Chiorazzi, N., Budman, D., Teichberg, S., and, Xu, H. P., (2002) TSP50, a possible protease in human testes, is activated in breast cancer epithelial cells. Cancer Res. 62, 290-294. (Pubitemid 34074017)
4. Xu, H. P., Yuan, L., Shan, J., and, Feng, H., (2004) Localization and expression of TSP50 protein in human and rodent testes. Urology 64, 826-832. (Pubitemid 39446083)
5. Beard, J., (1905) The cancer problem. 1. Lancet 165, 281-283.
6. Beard, J., and, Shaw-Mackenzie, J., (1905) The cancer problem and cancer research. Lancet 165, 385-386.
7. Gurchot, C., (1975) The trophoblast theory of cancer (John Beard, 1857-1924) revisited. Oncology 31, 310-333.
8. Coulie, P. G., Brichard, V., Van Pel, A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., Renauld, J. C., and, Boon, T., (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180, 35-42. (Pubitemid 24181053)
9. Fisk, B., Blevins, T. L., Wharton, J. T., and, Ioannides, C. G., (1995) Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J. Exp. Med. 181, 2109-2117.
10. Disis, M. L., and, Cheever, M. A., (1996) Oncogenic proteins as tumor antigens. Curr. Opin. Immunol. 8, 637-642. (Pubitemid 26385391)
11. Chen, Y. T., Scanlan, M. J., Sahin, U., Tureci, O., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., and, Old, L. J., (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA. 94, 1914-1918. (Pubitemid 27113936)
12. Scanlan, M. J., Chen, Y. T., Williamson, B., Gure, A. O., Stockert, E., Gordan, J. D., Tureci, O., Sahin, U., Pfreundschuh, M., and, Old, L. J., (1998) Characterization of human colon cancer antigens recognized by autologous antibodies. Int. J. Cancer. 76, 652-658. (Pubitemid 28243936)
13. Old, L. J., (2001) Cancer/testis (CT) antigens-a new link between gametogenesis and cancer. Cancer Immun. 1, 1.
14. Kirkin, A. F., Dzhandzhugazyan, K. N., and, Zeuthen, J., (2002) Cancer/testis antigens: structural and immunobiological properties. Cancer Invest. 20, 222-236. (Pubitemid 34205490)
15. Heinzer, C., Susens, U., Schmitz, T. P., and, Borgmeyer, U., (1998) Retinoids induce differential expression and DNA binding of the mouse germ cell nuclear factor in P19 embryonal carcinoma cells. Biol, Chem. 379, 349-359. (Pubitemid 28152100)
16. van der Heyden, M. A., and, Defize, L. H., (2003) Twenty one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation. Cardiovasc. Res. 58, 292-302. (Pubitemid 36570388)
17. McBurney, M. W., Jones-Villeneuve, E. M., Edwards, M. K., and, Anderson, P. J., (1982) Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 299, 165-167. (Pubitemid 12056794)
18. Edwards, M. K., Harris, J. F., and, McBurney, M. W., (1983) Induced muscle differentiation in an embryonal carcinoma cell line. Mol. Cell. Biol. 3, 2280-2286. (Pubitemid 14224711)
19. Bulavin, D. V., Phillips, C., Nannenga, B., Timofeev, O., Donehower, L. A., Anderson, C. W., Appella, E., and, Fornace, A. J., Jr., (2004) Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 36, 343-350. (Pubitemid 38437256)
20. Choi, S. C., Choi, J. H., Shim, W. J., and, Lim, D. S., (2008) P19 embryonal carcinoma cells: a new model for the study of endothelial cell differentiation. Biotechnol. Lett. 30, 1169-1175.
21. Sharpless, N. E., Ramsey, M. R., Balasubramanian, P., Castrillon, D. H., and, DePinho, R. A., (2004) The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis. Oncogene 23, 379-385. (Pubitemid 38174991)
22. Zhang, J., Yang, M., Xu, Z. L., Bao, Y. L., Wu, Y., Wang, Y. Z., Meng, X. Y., Ju, X. D., Gu, Y., and, Li, Y. X., (2006) Preparation of polyclonal antibodies against testis-specific protease 50 and characterization of antibody specificity. Chem. Res. Chin. Univ. 22, 308-311. (Pubitemid 44136628)
23. Zhang, Y., Bao, Y. L., Wu, Y., Yu, C. L., Sun, Y., and, Li, Y. X., (2010) Identification and characterization of the human SLC5A8 gene promoter. Cancer. Genet. Cytogenet. 196, 124-132.
24. Zhang, Y., Zhou, L., Bao, Y. L., Wu, Y., Yu, C. L., Huang, Y. X., Sun, Y., Zheng, L. H., and, Li, Y. X., (2010) Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells. Chem. Biol. Interact. 185, 174-181.
25. Kanamaru, H., and, Yoshida, O., (1989) Assessment of in vitro lymphokine activated killer (LAK) cell activity against renal cancer cell lines and its suppression by serum factor using crystal violet assay. Urol. Res. 17, 259-264. (Pubitemid 19187289)
26. Zhang, Y., Bao, Y. L., Yang, M. T., Wu, Y., Yu, C. L., Huang, Y. X., Sun, Y., Zheng, L. H., and, Li, Y. X., (2010) Activin A induces SLC5A8 expression through the Smad3 signaling pathway in human colon cancer RKO cells. Int. J. Biochem. Cell. Biol.
27. Liang, C. C., Park, A. Y., and, Guan, J. L., (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2, 329-333. (Pubitemid 47040047)
28. Daniel, B., and, DeCoster, M. A., (2004) Quantification of sPLA2-induced early and late apoptosis changes in neuronal cell cultures using combined TUNEL and DAPI staining. Brain Res. Brain Res. Protoc. 13, 144-150. (Pubitemid 39030774)
29. Agarwal, M. L., Taylor, W. R., Chernov, M. V., Chernova, O. B., and, Stark, G. R., (1998) The p53 network. J. Biol. Chem. 273, 1-4. (Pubitemid 28042164)
30. Levine, A. J., (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331. (Pubitemid 27131374)
31. Vousden, K. H., and, Lane, D. P., (2007) p53 in health and disease. Nat. Rev. Mol. Cell. Biol. 8, 275-283. (Pubitemid 46474662)
32. Lowe, S. W., Bodis, S., Bardeesy, N., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Jacks, T., Pelletier, J., and, Housman, D. E., (1994) Apoptosis and the prognostic significance of p53 mutation. Cold Spring Harb. Symp. Quant. Biol. 59, 419-426.
33. Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E., and, Kotamraju, S., (2002) Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol. Cell. Biochem. 234-235, 119-124. (Pubitemid 34777848)
34. Taylor, C. W., Dalton, W. S., Parrish, P. R., Gleason, M. C., Bellamy, W. T., Thompson, F. H., Roe, D. J., and, Trent, J. M., (1991) Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br. J. Cancer. 63, 923-929.
35. Wang, S., Konorev, E. A., Kotamraju, S., Joseph, J., Kalivendi, S., and, Kalyanaraman, B., (2004) Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways. J. Biol. Chem. 279, 25535-25543. (Pubitemid 38756813)
36. Chen, S. T., Pan, T. L., Tsai, Y. C., and, Huang, C. M., (2002) Proteomics reveals protein profile changes in doxorubicin - treated MCF-7 human breast cancer cells. Cancer Lett. 181, 95-107.
37. Liu, X., Chua, C. C., Gao, J., Chen, Z., Landy, C. L., Hamdy, R., and, Chua, B. H., (2004) Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am. J. Physiol. Heart Circ. Physiol. 286, H933-H939. (Pubitemid 38248606)
38. Meulmeester, E., and, Jochemsen, A. G., (2008) p53: a guide to apoptosis. Curr Cancer Drug Targets 8, 87-97. (Pubitemid 351347244)
39. Riley, T., Sontag, E., Chen, P., and, Levine, A., (2008) Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 9, 402-412. (Pubitemid 351574202)
40. Goping, I. S., Gross, A., Lavoie, J. N., Nguyen, M., Jemmerson, R., Roth, K., Korsmeyer, S. J., and, Shore, G. C., (1998) Regulated targeting of BAX to mitochondria. J. Cell Biol. 143, 207-215. (Pubitemid 28480529)
41. Pietrzak, M., and, Puzianowska-Kuznicka, M., (2008) p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter. Biol. Chem. 389, 383-393. (Pubitemid 351773909)
42. Sgambato, A., Cittadini, A., Faraglia, B., and, Weinstein, I. B., (2000) Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. J. Cell. Physiol. 183, 18-27. (Pubitemid 30130221)
43. Kothapalli, D., Zhao, L., Hawthorne, E. A., Cheng, Y., Lee, E., Pure, E., and, Assoian, R. K., (2007) Hyaluronan and CD44 antagonize mitogen-dependent cyclin D1 expression in mesenchymal cells. J Cell Biol. 176, 535-544.
44. Agami, R., and, Bernards, R., (2000) Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102, 55-66.
45. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and, Elledge, S. J., (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816. (Pubitemid 23346377)
46. Lloyd, R. V., Erickson, L. A., Jin, L., Kulig, E., Qian, X., Cheville, J. C., and, Scheithauer, B. W., (1999) p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol. 154, 313-323. (Pubitemid 29094081)
47. Miyashita, T., and, Reed, J. C., (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
48. Wang, Y., Okan, I., Szekely, L., Klein, G., and, Wiman, K. G., (1995) bcl-2 inhibits wild-type p53-triggered apoptosis but not G1 cell cycle arrest and transactivation of WAF1 and bax. Cell Growth Differ. 6, 1071-1075.